PHILIPS AVENT M I L K B O T T L E S E A L • FDA, EU & China fatty food contact regulations • Provided a tight seal at elevated temperatures for sterilization • Can cater to repeated refrigeration • Utilized material expertise to develop a product to meet fatty food contact regulations and offer safe sealing performance • Enabled mothers to convert their Philips AVENT bottles into breast milk storage containers Versaflex™ FFC2882-87 Thermoplastic Elastomer KEY REQUIREMENTS AVIENT SOLUTION REGULATORY COMPLIANCE LEARN MORE WHY AVIENT?

BIO additives MR snapshot 2022 Final EXTRUSION CAST PROCESSOR T H I N P L A F I L M & B A G S • Non-stick performance during manufacturing • Excellent film quality with good aesthetics • Efficient and clean process performance • Compliant with food contact applications* • Provided a performance additive to prevent biodegradable resin from sticking to the chill-roll surface • Reduced the polymer friction factor on metal surfaces, resulting in a better film quality • Helped improve the manufacturing process with fewer cleaning steps CESA™ OnCap™ & BIO Additives KEY REQUIREMENTS WHY AVIENT? Contact Avient for conditions of use and limitations.

The Consultant maintains regular contact with the Compensation Committee and interacts with management to gather the data needed to prepare reports for Compensation Committee review. Eastman Chemical Company The Scotts Miracle-Gro Company Ashland Global Holdings Inc. Fuller Company Trinseo S.A.

Contact Avient for more information or to discuss your specific application. Contact Avient for more information or to discuss your specific application. Contact Avient for more information or to discuss your specific application.

Includes estimated full year performance of APM acquisition ** 2019 baseline data revised to account for acquisition pro-forma performance and divestitures ¹Refer to CDP Climate Change Report for finalized Energy/Emissions information at https://www.avient.com/company/sustainability/sustainability-report/reporting/cdp-climate-change-report  ⁴Certificates can be found at https://www.avient.com/company/policies-and-governance/global-iso-certificate-library

US FDA and EU food contact information is available on request. ANTIOXIDANTS FOR METAL/PP-R AND PP-RCT SYSTEMS Plastic systems in contact with metal inserts can also be subject to oxidization. Contact your Avient sales representative for more information.

Contact us today for small order quantity orders. Contact your FIBER-LINE® representative for exact product details which conform to your specific requirements. Contact us today for small order quantity orders.

The Consultant maintains regular contact with the Compensation Committee and interacts with management to gather the data needed to prepare reports for Compensation Committee review. We also look at the freff quency with which these companies were used as peers by other companies in our industry and which companies had identifieff d PolyOne as a peer. To obtain comparability based on company size, the Consultant’s analysis either referff enced a specific sample of comparably-sized companies or calibrated the pay of a broad sample of companies against company size.

Review and approve (a) attainment levels under the Company’s annual incentive plan; (b) payments to executive officers of the Company under the annual incentive plan; and (c) payments to officers, senior managers and employees of the Company under the Company’s long-term incentive compensation plans Review and assess risks arising from the Company’s compensation policies and practices for its executive officers and employees, and whether any such risks are reasonably likely to have a material adverse effect on the Company With the assistance of management and any outside advisers the Committee deems appropriate (a) review and discuss with management the Company’s disclosures in the CD&A, and, based on this review, make a recommendation as to whether to include it in the Company’s annual report on Form 10-K and proxy statement relating to the Company’s annual meeting of shareholders, and (b) prepare a Compensation Committee Report for inclusion in the Company’s proxy statement or other applicable SEC filings. 4 Board Reports and Annual Evaluation

 Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:  The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated savings and operational benefits from the asset realignment;  Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;  Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;  An inability to raise or sustain prices for products or services;  An inability to maintain appropriate relations with unions and employees;  The inability to achieve expected results from our acquisition activities;  Our ability to continue to pay cash dividends;  The amount and timing of repurchases of our common shares, if any; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation  PolyOne’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of the Company and each business segment and to allocate resources. Patterson President and Chief Executive Officer PolyOne Corporation Page 36 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 37 Innovation Drives Earnings Growth $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 PolyOne Corporation Page 38 Formula for Success Innovation Market Beating Performance Excellence in Execution PolyOne Corporation Page 39 Track Record of Successful Integrations and Rapid Operating Income Growth $12 $44 2007 2013 $22 $30 2012 2013 $24 $49 2012 2013 GLS ColorMatrix Spartech OI in $ millions PolyOne Corporation Page 40 2015 and Beyond Innovation will drive the next stage in our remarkable transformation Deliver on 2015 goals Expand Specialty offerings and possibilities Identified as a truly global, specialty chemical company Market Potential Exceeds $40 Billion PolyOne Corporation Page 41 Driving Toward Premier Profitability EBIT Margins for top tier companies Victrex 42% Sigma Aldrich 18% FMC 25% IFF 18% Eastman 17% Hexcel 16% 16% Rockwood Holdings Celanese 14% 7% EBIT Margin – 2013 Albemarle 24% Ecolab 13% PolyOne Corporation Page 42 Bright Future & High Aspirations – The Next Seven Years • % OP Income from Specialty - 5% • Market Cap - $500 Million • Revenue - $2.6 Billion • Commodity Peers • Specialty ROS - 1.5% • % OP Income from Specialty - 62% • Market Cap - $3.5 Billion • Revenue - $3.7 Billion • Specialty ROS - 9.4% • % OP Income from Specialty - 80 to 90% • Market Cap - $12 to $18 Billion • Revenue - $8 to $10 Billion • Specialty Peers • Specialty ROS - ≥ 20% 2000 – 2006 2007 – 2013 2014 – 2020 PolyOne Corporation Page 43 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?